Drug Profile
Triflusal
Alternative Names: Aflen; Disgren; Tecnosal; Triflux; UR 1501Latest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator Uriach
- Class Antiplatelets; Salicylates
- Mechanism of Action Cyclooxygenase inhibitors; Platelet aggregation inhibitors; Thromboxane A2 synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Myocardial infarction; Thromboembolism; Unstable angina pectoris
- Discontinued Alzheimer's disease; Dementia; Stroke
Most Recent Events
- 03 Aug 2007 Discontinued - Phase-I for Alzheimer's disease in Europe (unspecified route)
- 03 Aug 2007 Discontinued - Phase-I for Dementia in Europe (unspecified route)
- 03 Aug 2007 Discontinued - Phase-II for Stroke in Argentina (PO)